Skip to Content

LATANOPROST DR. MANN PHARMA 0.05 MG/ ML EYE DROPS SOLUTION

Active substance(s): LATANOPROST

View full screen / Print PDF » Download PDF ⇩
Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER
Latanoprost Dr. Mann Pharma, 50 micrograms/ml, eye drops, solution
Latanoprost
Read all of this leaflet carefully before you start using this medicine.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to others. It
may harm them, even if their symptoms are the same as yours.
If any of the side effects gets serious, or if you notice any side effects not
listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1.
What Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann Pharma is and
what it is used for
2.
Before you use Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann
Pharma
3.
How to use Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann Pharma
4.
Possible side effects
5.
How to store Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann Pharma
6.
Further information
1.

WHAT LATANOPROST DR. MANN PHARMALATANOPROST DR. MANN
PHARMA IS AND WHAT IT IS USED FOR

The name of your medicine is Latanoprost Dr. Mann PharmaLatanoprost Dr.
Mann Pharma.
It is only for use in your eyes.
The active ingredient in Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann
Pharma is one of a group of medicines known as prostaglandins. It lowers the
pressure within your eye by increasing the natural flow of fluid from inside the
eye out into the blood stream.
Latanoprost Dr. Mann PharmaLatanoprost Dr. Mann Pharma is used to treat a
type of glaucoma called open angle glaucoma and also a condition known as
ocular hypertension. Both of these conditions can be linked with an increase in
the pressure within your eye and eventually they may affect your eyesight.
2.

BEFORE YOU USE LATANOPROST DR. MANN PHARMA

DO NOT use Latanoprost Dr. Mann Pharma
if you are allergic (hypersensitive) to the active substance latanoprost or
any of the other ingredients of Latanoprost Dr. Mann Pharma (These are
listed at section 6 of the leaflet.)
Take special care with Latanoprost Dr. Mann Pharma
Before using your medicine you should tell your doctor if:

-

You have severe asthma, or your asthma is not well controlled.
you have any other types of glaucoma.
you have inflammatory conditions of your eye, eg conjunctivitis.
you have no lens or an artificial lens in the eye (aphakia or pseudophakia).
you have a closed or blocked retinal vein (retinal vein occlusion).
you have diabetes which is affecting the eyes (diabetic retinopathy).
you are susceptible to inflammation of the iris or the middle layer of the eye
(iritis/uveitis).
you are about to have or have had eye surgery.

Latanoprost Dr. Mann Pharma may cause a gradual change in the eye colour and
this may become permanent. Ask your doctor for more information.
While using Latanoprost Dr. Mann Pharma you should have regular eye
examinations.
Children
Latanoprost Dr. Mann Pharma is not recommended for the use in
children/adolescents below 18 years due to a lack of data of safety and efficacy.
Using other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any
other medicines, including medicines obtained without a prescription.
You should not use other eyedrops which belongs to the same group of medicines
(prostaglandins). Ask your doctor for advice if you are not sure.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine.
You should not use the eye drops if you are pregnant, think you might be
pregnant or you are planning a pregnancy.
You should not use the eye drops if you are breast feeding a baby.
Driving and using machines
As with other eye drops, if your vision is blurred when you first put your drops in,
wait until this wears off before you drive or operate machinery.
Important information about some of the ingredients of Latanoprost Dr.
Mann Pharma
This medicinal product contains benzalkonium chloride which may cause eye
irritation. Avoid contact with soft contact lenses. Remove contact lenses prior to
application and wait at least 15 minutes before putting them back in.
Benzalkonium chloride is known to discolour soft contact lenses.
Contact lens wearers:
Avoid contact with soft contact lenses. If you wear contact lenses, remove them
prior to application and wait at least 15 minutes before reinsertion. The
preservative benzalkonium chloride is known to discolour soft contact lenses.
3.

HOW TO USE LATANOPROST DR. MANN PHARMA

Always use Latanoprost Dr. Mann Pharma exactly as your doctor has told you.
You should check with your doctor or pharmacist if you are not sure.
Instructions for Latanoprost Dr. Mann Pharma use:
The usual dose is one drop of Latanoprost Dr. Mann Pharma into the affected
eye(s) once daily.
The best time to do this is in the evening.
If you have to use other eye drops you should wait for at least 5 minutes before
using them.
If you wear contact lenses, remove them before using Latanoprost Dr. Mann
Pharma. You may reinsert them after 15 minutes.
This is the usual dose for adults, including elderly patients. Latanoprost Dr. Mann
Pharma is not normally used in children.
Follow the steps below to help you use Latanoprost Dr. Mann Pharma properly:
1. Wash your hands and sit or stand comfortably.
2. Twist off the cap.
3. Use your finger to gently pull down the lower eyelid of your affected eye.
4. Place the tip of the bottle close to, but not touching your eye.
5. Squeeze the bottle gently so that only one drop goes into your eye, then
release the lower eyelid.
6. Press a finger against the corner of the affected eye by the nose. Hold for 1
minute whilst keeping the eye closed.
7. Repeat in your other eye if your doctor has told you to do this.
8. Put the cap back on the bottle.

How long should you use your medicine for?
Latanoprost Dr. Mann Pharma should be used until your doctor tells you to stop.
If you use more Latanoprost Dr. Mann Pharma than you should
Be careful when you are squeezing the bottle so that you only put one drop into
the affected eye. If you put too many drops in your eye, you may feel some
slight irritation in the eye. Ask your doctor for advice.
If Latanoprost Dr. Mann Pharma is accidentally swallowed, you should contact
your doctor.
If you forget to use Latanoprost Dr. Mann Pharma
If you forget to use your eye drops at the usual time, wait until it is time for your
next dose.

Do not put an extra drop into your eye to make up for the one you may have
missed.
If you have any further questions on the use of this product, ask your doctor or
pharmacist.
4.

POSSIBLE SIDE EFFECTS

Like all medicines, Latanoprost Dr. Mann Pharma can cause side effects, although
not everybody gets them.
Stop using Latanoprost Dr. Mann Pharma and contact your doctor immediately
if:.
- you notice changes in your vision that did not always occur just after
administering the drops. These changes may mean that reading and being
able to see fine detail is difficult.
- you feel as if there is something in your eye(s).
- your eye(s) water and become red or painful and/or your vision becomes
blurred.
- your eye lid(s) look swollen, puffy or feel sore.
The evaluation of the side effects is based on the following frequencies:







Very common side effects (affects more than 1 user in 10)
Common side effects (affects 1 to 10 users in 100)
Uncommon side effects (affects 1 to 10 users in 1,000)
Rare side effects (affects 1 to 10 users in 10,000)
Very rare: affects less than 1 user in 10,000
Not known: frequency cannot be estimated from the available data.

Eye Disorders:
Very common:
- Over an extended period of treatment there may be a gradual and slight
change in eye colour. This is typically seen in the first 8 months. Patient’s
most likely to be affected are those with mixed coloured irises, e.g. bluebrown, grey-brown, yellow-brown and green-brown. The colour change is
slight in most of cases and not observed clinically. The Iris may appear
more brownish, due to an increase in melanin pigmentation. Ask your
doctor for more information (increased iris pigmentation);
- red eye due to increased blood supply (mild to moderate conjunctival
hyperaemia);
- eye irritation (burning grittiness, itching, stinging and foreign body
sensation);
- eyelash and vellus hair changes (increased length, thickness, pigmentation
and number)
Common:
- temporary punctate epithelial erosions of the cornea, mostly without
symptoms;
- Inflammation of the eyelid (blepharitis);
- eye pain.

Uncommon:
- swelling of the eyelid due to excess fluid retention (eyelid oedema);
- dry eye;
- Inflammation of the cornea (keratitis);
- vision blurred;
- conjunctivitis.
Rare:
- Inflammation of the iris or middle layer of the eye (iritis/uveitis) (the
majority of reports in patients with concomitant risk factors);
- swelling of the area at the back of the eye responsible for seeing fine detail
(macular oedema);
- swelling or erosions of the corneal (symptomatic corneal oedema and
erosions); blurred vision or the appearance of halos around lights
- swelling around the eyes (periorbital oedema);
- eyelashes may grow in the "wrong" direction sometimes resulting in eye
irritation;
- extra row of lashes (distichiasis).

Cardiac Disorders:
Very rare:
- patients with angina have experienced worsening of their chest pain
symptoms.
Frequency not known:
- feeling your heartbeat (palpitations).
Respiratory Disorders:
Rare:
- asthma,
- worsening of asthma and breathlessness.
Skin Disorders:
Uncommon:
- skin rash.
Rare:
- localised skin reaction on the eyelids;
- darkening of the eyelids and the skin around the eyes.
General Disorders
Very rare:
- chest pain.
Frequency not known:
- headache,
- dizziness.
Musculoskeletal and Connective Tissue Disorders:
Frequency not known:
- pain in the muscles (myalgia);
- pain in the joints (arthralgia).

If you experience any of these side effects and are concerned please tell your
doctor as soon as possible.
If any of the side effects gets serious, or if you notice any side effects not listed
in this leaflet, please tell your doctor or pharmacist.
5.

HOW TO STORE LATANOPROST DR. MANN PHARMA

Before Latanoprost Dr. Mann Pharma is first opened, Store and transport
refrigerated (2°C – 8°C).
Keep the bottle in the outer carton in order to protect from light.
After opening, do not store above 25°C.
Each bottle should be thrown away 4 weeks after first opening.
Do not use Latanoprost Dr. Mann Pharma after the expiry date which is stated on
the carton after EXP. The expiry date refers to the last day of that month.
Keep out of the reach and sight of children.
Medicines should not be disposed of via wastewater or household waste. Ask your
pharmacist how to dispose of medicines no longer required. These measures will
help to protect the environment.
6.

FURTHER INFORMATION

What Latanoprost Dr. Mann Pharma contains
The active substance is latanoprost. Each ml contains 50 micrograms latanoprost.
2.5 ml of eye drops, solution (content of a bottle) contains 125 micrograms of
latanoprost.
The other ingredients are:
- benzalkonium chloride 0.2 mg/ml
- sodium chloride
- sodium dihydrogen phosphate monohydrate
- disodium phosphate anhydrous
- water, purifed
What Latanoprost Dr. Mann Pharma looks like and contents of the pack
The eye drops are a colourless or pale-yellow, clear solution.
Each bottle contains 2.5 ml eye drops, solution.
Latanoprost Dr. Mann Pharma is available in the following pack sizes: one bottle
of 2.5 ml, 3 bottles of 2.5 ml and 6 bottles of 2.5 ml.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Brunsbütteler Damm 165-173
13581 Berlin

Germany
Telephone:+49 (0)30 33093-0
Fax:+49 (0)30 33093-350

This medicinal product is authorized in the Member States of the EEA
under the following names:
United Kingdom
Germany

Latanoprost Dr. Mann Pharma
Arulatan

This leaflet was last approved in 07/2010.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide